Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sigma Xi | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
The purpose of this research study is to examine the effect of high-fat meals on the health of blood vessels. In addition, the study will examine how exercise/fitness/physical activity impacts blood vessels after consumption of a high-fat meal.
This is the first in a series of studies examining the impact of high-fat meals on blood vessels. During the preliminary visit of this study, eligible participants' resting metabolic rate, arm flow mediated dilation, and leg flow mediate dilation will be measured. They will complete handgrip and plantar flexion exercise tasks. Finally, they will be given a physical activity monitor to wear for 7 days. At their first visit, participants will eat a high-fat meal and blood will be drawn to measure blood vessel health. They will also repeat the arm flow mediated dilation, leg flow mediate dilation, handgrip, and plantar flexion exercise tests.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Low physical activity/fitness | Other | Participants will be classified as into low-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing. |
|
| High physical activity/fitness | Other | Participants will be classified as into high-physical fitness based on self-reported physical activity and cardiorespiratory fitness testing. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High-fat meal | Other | Participants will be given a serving of Marie Callendar's Chocolate Satin Pie to eat over a period of 20 minutes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Fasting triglycerides | Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans. | Baseline |
| Post HFM Triglycerides | Ester derived from glycerol and three fatty acids, representative of the main constituent of body fat in humans. | 4 hours |
| Fasting total cholesterol | Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall. | Baseline |
| Post HFM total cholesterol | Type of lipid that is required for cell structure, but can contribute to increased risk of heart disease if high due to development of fatty deposits on vascular wall. | 4 hours |
| Fasting LDL | Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol. | Baseline |
| Post HFM LDL | Low density lipoprotein that transports fat molecules in the body. Associated with high levels of cholesterol. | 4 hours |
| Fasting HDL | High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation. | Baseline |
Not provided
Not provided
Inclusion Criteria:
f.) for female participants, presence of a normal, monthly menstrual cycle with or without prescribed contraceptive methods.
.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robert L Franco, PhD | Virginia Commonwealth University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006949 | Hyperlipidemias |
| ID | Term |
|---|---|
| D050171 | Dyslipidemias |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Post HFM HDL | High density lipoprotein that transports fat molecules in the body. Associated with carrying cholesterol to the liver for degradation. | 4 hours |
| Fasting non-HDL | Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease. | Baseline |
| Post HFM non-HDL | Total cholesterol minus HDL, often associated with a better assessment of risk for heart disease. | 4 hours |
| Fasting LDL/HDL ratio | Assessment of risk for heart disease. | Baseline |
| Post HFM LDL/HDL ratio | Assessment of risk for heart disease. | 4 hours |
| Fasting anti-inflammatory surface receptor expression | CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages. | Baseline |
| Post HFM anti-inflammatory surface receptor expression | CD14, CD206 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages. | 4 hours |
| Fasting pro-inflammatory surface receptor expression | CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages. | Baseline |
| Post HFM pro-inflammatory surface receptor expression | CD16, CD86 - monocyte receptors associated with defining subsets and inflammatory differentiation of macrophages. | 4 hours |
| Fasting brachial artery flow-mediated dilation | Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound. | Baseline |
| Post HFM brachial artery flow-mediated dilation | Dilation of brachial artery when blood flow increases in artery. Measured by non-invasive ultrasound. | 5.5 hours |
| Fasting superficial artery flow-mediated dilation | Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound. | Baseline |
| Post HFM superficial artery flow-mediated dilation | Dilation of superficial artery when blood flow increases in artery. Measured by non-invasive ultrasound. | 5.5 hours |